FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767544174> ?p ?o ?g. }

• W2767544174 endingPage "163" @default.
• W2767544174 startingPage "150" @default.
• W2767544174 abstract "Essentials•Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP).•Obese ADAMTS‐13‐deficient mice were triggered with von Willebrand factor (VWF).•Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model.•VWF enhances phagocytosis of platelets by macrophages, dose‐dependently.Summary: BackgroundThrombotic thrombocytopenic purpura (TTP) is caused by the absence of ADAMTS‐13 activity. Thrombocytopenia is presumably related to the formation of microthrombi rich in von Willebrand factor (VWF) and platelets. Obesity may be a risk factor for TTP; it is associated with abundance of macrophages that may phagocytose platelets.ObjectivesTo evaluate the role of obesity and ADAMTS‐13 deficiency in TTP, and to establish whether macrophages contribute to thrombocytopenia.MethodsLean or obese ADAMTS‐13‐deficient (Adamts‐13−/−) and wild‐type (WT) mice were injected with 250 U kg−1 of recombinant human VWF (rVWF), and TTP characteristics were evaluated 24 h later. In separate experiments, macrophages were depleted in the liver and spleen of lean and obese WT or Adamts‐13−/− mice by injection of clodronate‐liposomes, 48 h before injection of rVWF.ResultsObese Adamts‐13−/− mice had a lower platelet count than their lean counterparts, suggesting that they might be more susceptible to TTP development. Lean Adamts‐13−/− mice triggered with a threshold dose of rVWF did not develop TTP, whereas typical TTP symptoms developed in obese Adamts‐13−/− mice, including severe thrombocytopenia and higher lactate dehydrogenase (LDH) levels. Removal of hepatic and splenic macrophages by clodronate injection in obese Adamts‐13−/− mice before treatment with rVWF preserved the platelet counts measured 24 h after the trigger. In vitro experiments with cultured macrophages confirmed a VWF dose‐dependent increase of platelet phagocytosis.ConclusionsObese Adamts‐13−/− mice are more susceptible to the induction of TTP‐related thrombocytopenia than lean mice. Phagocytosis of platelets by macrophages contributes to thrombocytopenia after rVWF injection in this model. Essentials•Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP).•Obese ADAMTS‐13‐deficient mice were triggered with von Willebrand factor (VWF).•Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model.•VWF enhances phagocytosis of platelets by macrophages, dose‐dependently. •Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP).•Obese ADAMTS‐13‐deficient mice were triggered with von Willebrand factor (VWF).•Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model.•VWF enhances phagocytosis of platelets by macrophages, dose‐dependently. Thrombotic thrombocytopenic purpura (TTP) is caused by the absence of ADAMTS‐13 activity. Thrombocytopenia is presumably related to the formation of microthrombi rich in von Willebrand factor (VWF) and platelets. Obesity may be a risk factor for TTP; it is associated with abundance of macrophages that may phagocytose platelets. To evaluate the role of obesity and ADAMTS‐13 deficiency in TTP, and to establish whether macrophages contribute to thrombocytopenia. Lean or obese ADAMTS‐13‐deficient (Adamts‐13−/−) and wild‐type (WT) mice were injected with 250 U kg−1 of recombinant human VWF (rVWF), and TTP characteristics were evaluated 24 h later. In separate experiments, macrophages were depleted in the liver and spleen of lean and obese WT or Adamts‐13−/− mice by injection of clodronate‐liposomes, 48 h before injection of rVWF. Obese Adamts‐13−/− mice had a lower platelet count than their lean counterparts, suggesting that they might be more susceptible to TTP development. Lean Adamts‐13−/− mice triggered with a threshold dose of rVWF did not develop TTP, whereas typical TTP symptoms developed in obese Adamts‐13−/− mice, including severe thrombocytopenia and higher lactate dehydrogenase (LDH) levels. Removal of hepatic and splenic macrophages by clodronate injection in obese Adamts‐13−/− mice before treatment with rVWF preserved the platelet counts measured 24 h after the trigger. In vitro experiments with cultured macrophages confirmed a VWF dose‐dependent increase of platelet phagocytosis. Obese Adamts‐13−/− mice are more susceptible to the induction of TTP‐related thrombocytopenia than lean mice. Phagocytosis of platelets by macrophages contributes to thrombocytopenia after rVWF injection in this model." @default.
• W2767544174 created "2017-11-17" @default.
• W2767544174 creator A5001693242 @default.
• W2767544174 creator A5003215371 @default.
• W2767544174 creator A5006329944 @default.
• W2767544174 creator A5006993755 @default.
• W2767544174 creator A5010065750 @default.
• W2767544174 creator A5015282498 @default.
• W2767544174 creator A5017438245 @default.
• W2767544174 creator A5037007899 @default.
• W2767544174 date "2018-01-01" @default.
• W2767544174 modified "2023-10-16" @default.
• W2767544174 title "Platelet rescue by macrophage depletion in obese ADAMTS‐13‐deficient mice at risk of thrombotic thrombocytopenic purpura" @default.
• W2767544174 cites W1683190842 @default.
• W2767544174 cites W1900627495 @default.
• W2767544174 cites W1991448591 @default.
• W2767544174 cites W1993862762 @default.
• W2767544174 cites W1998209313 @default.
• W2767544174 cites W2000863779 @default.
• W2767544174 cites W2028053287 @default.
• W2767544174 cites W2030872629 @default.
• W2767544174 cites W2042414158 @default.
• W2767544174 cites W2051131128 @default.
• W2767544174 cites W2053956729 @default.
• W2767544174 cites W2056644419 @default.
• W2767544174 cites W2061532259 @default.
• W2767544174 cites W2067227158 @default.
• W2767544174 cites W2071260560 @default.
• W2767544174 cites W2076574609 @default.
• W2767544174 cites W2079494621 @default.
• W2767544174 cites W2101061562 @default.
• W2767544174 cites W2111825680 @default.
• W2767544174 cites W2112791998 @default.
• W2767544174 cites W2140933814 @default.
• W2767544174 cites W2145352772 @default.
• W2767544174 cites W2157827945 @default.
• W2767544174 cites W2164442831 @default.
• W2767544174 cites W2164834459 @default.
• W2767544174 cites W2171752155 @default.
• W2767544174 cites W2317056394 @default.
• W2767544174 cites W2511799783 @default.
• W2767544174 cites W2513984924 @default.
• W2767544174 cites W2537466022 @default.
• W2767544174 cites W2604565584 @default.
• W2767544174 cites W4249727000 @default.
• W2767544174 doi "https://doi.org/10.1111/jth.13901" @default.
• W2767544174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29121438" @default.
• W2767544174 hasPublicationYear "2018" @default.
• W2767544174 type Work @default.
• W2767544174 sameAs 2767544174 @default.
• W2767544174 citedByCount "3" @default.
• W2767544174 countsByYear W27675441742019 @default.
• W2767544174 countsByYear W27675441742020 @default.
• W2767544174 countsByYear W27675441742022 @default.
• W2767544174 crossrefType "journal-article" @default.
• W2767544174 hasAuthorship W2767544174A5001693242 @default.
• W2767544174 hasAuthorship W2767544174A5003215371 @default.
• W2767544174 hasAuthorship W2767544174A5006329944 @default.
• W2767544174 hasAuthorship W2767544174A5006993755 @default.
• W2767544174 hasAuthorship W2767544174A5010065750 @default.
• W2767544174 hasAuthorship W2767544174A5015282498 @default.
• W2767544174 hasAuthorship W2767544174A5017438245 @default.
• W2767544174 hasAuthorship W2767544174A5037007899 @default.
• W2767544174 hasBestOaLocation W27675441741 @default.
• W2767544174 hasConcept C109523444 @default.
• W2767544174 hasConcept C126322002 @default.
• W2767544174 hasConcept C134018914 @default.
• W2767544174 hasConcept C167814343 @default.
• W2767544174 hasConcept C185592680 @default.
• W2767544174 hasConcept C202751555 @default.
• W2767544174 hasConcept C203014093 @default.
• W2767544174 hasConcept C2776224515 @default.
• W2767544174 hasConcept C2778585876 @default.
• W2767544174 hasConcept C2779244956 @default.
• W2767544174 hasConcept C2779394231 @default.
• W2767544174 hasConcept C2780931953 @default.
• W2767544174 hasConcept C55493867 @default.
• W2767544174 hasConcept C55728118 @default.
• W2767544174 hasConcept C65245452 @default.
• W2767544174 hasConcept C71924100 @default.
• W2767544174 hasConcept C89560881 @default.
• W2767544174 hasConceptScore W2767544174C109523444 @default.
• W2767544174 hasConceptScore W2767544174C126322002 @default.
• W2767544174 hasConceptScore W2767544174C134018914 @default.
• W2767544174 hasConceptScore W2767544174C167814343 @default.
• W2767544174 hasConceptScore W2767544174C185592680 @default.
• W2767544174 hasConceptScore W2767544174C202751555 @default.
• W2767544174 hasConceptScore W2767544174C203014093 @default.
• W2767544174 hasConceptScore W2767544174C2776224515 @default.
• W2767544174 hasConceptScore W2767544174C2778585876 @default.
• W2767544174 hasConceptScore W2767544174C2779244956 @default.
• W2767544174 hasConceptScore W2767544174C2779394231 @default.
• W2767544174 hasConceptScore W2767544174C2780931953 @default.
• W2767544174 hasConceptScore W2767544174C55493867 @default.
• W2767544174 hasConceptScore W2767544174C55728118 @default.
• W2767544174 hasConceptScore W2767544174C65245452 @default.
• W2767544174 hasConceptScore W2767544174C71924100 @default.
• W2767544174 hasConceptScore W2767544174C89560881 @default.

• next